Spyre Therapeutics, Inc. (SYRE): auditor change — Spyre dismisses PwC as auditor, appoints KPMG; discloses material weakness in controls

Spyre Therapeutics, Inc.

PwC dismissed as auditor effective Feb 28, 2025; KPMG appointed as new independent auditor for FY2025.
No disagreements with PwC on accounting principles; material weakness identified as of Dec 31, 2024 in controls over EPS calculation for convertible preferred stock.
Material weakness led to restatement of FY2023 consolidated financial statements.
PwC's reports for FY2024 and FY2023 were unqualified.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Spyre Therapeutics, Inc. engaged KPMG LLP as its auditor.

Action: engagement
Auditor: KPMG LLP

Exact text from the filing

On February 28, 2025, the Audit Committee, after conducting a competitive process to determine the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025, appointed KPMG LLP (“KPMG”) as the independent registered public accounting firm of the Company for the year ending December 31, 2025, effective immediately.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Spyre Therapeutics, Inc. dismissed PricewaterhouseCoopers LLP as its auditor.

Action: dismissal
Auditor: PricewaterhouseCoopers LLP
Successor: KPMG LLP

Exact text from the filing

On February 28, 2025, the Audit Committee (the “Audit Committee”) of Board of Directors (the “Board”) of Spyre Therapeutics, Inc. (the “Company”), dismissed PricewaterhouseCoopers LLP (“PwC”) as the Company’s independent registered public accounting firm, effective immediately.

View on SEC.gov

8 auditor changes filed in the last 30 days. Browse all auditor changes →

Spyre Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-25-048423

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.